2015 Competition Deadline: 


2014 Guidelines for Post-Doctoral Fellowship

 

PRIORITY ANNOUNCEMENT
Knowledge Translation Post Doctoral Fellowship
Description

Eligibility

Conditions of Support

Tenure

Stipend

Paying of Stipend

Preparing Electronic Files

Application

 


Description

A KRESCENT program Post-Doctoral Fellowship is an “in-training” award intended for applicants with a PhD, MD or equivalent degree. The objective is to attract and foster young investigators to initiate and/or continue training in kidney research.

An awardee may not be in receipt of another major personnel award at the same time as holding the Post-Doctoral Fellowship from the KRESCENT program. However, the KRESCENT program will consider approving supplemental funding if a minor stipend has been provided from a local or provincial funding agency.

 

Eligibility

Applicants must be Canadian citizens or landed immigrants at the time of submission of their application.
 
Awards for a Post-Doctoral Fellowship are tenable under the supervision of investigators holding an academic appointment and in areas of investigation where it is clear that the research has direct relevance to kidney disease.  The training program must include involvement in actual research, and not only courses in research methods.  Applicants enrolled in programs oriented primarily toward professional specialty training are normally ineligible for the Post-Doctoral Fellowship.

Candidates with more than four years of Post-PhD research training by the competition deadline are not eligible to apply for this award.  Any interruption in a candidate’s Post-PhD research training will be taken into account in determining eligibility.

Applicants with a MD degree must hold license in Canada or be enrolled in a program leading to certification in Canada at the time of applying for this award.  Applicants may propose a program of research leading to a Master’s or PhD degree; however, registration in a graduate program is not a requirement.

Applications for training in clinical research will be considered only if it is clear from the application that at least 80% of the applicant’s time and effort will be devoted to the research project(s) and clinical activities upon which the research project(s) is immediately dependent.

Each application is considered to be a joint submission by the applicant and the proposed supervisor.  The research plan should be written in full consultation and agreement between the supervisor and the applicant.

 

Conditions of support

Each applicant must show evidence of having been accepted by a university department or affiliated institution acceptable to the KRESCENT program.

The tenure of the Post-Doctoral Fellowship is generally held at a Canadian university or affiliated research institutions.

The awardee must participate and successfully complete the KRESCENT Core Curriculum (for details see KRESCENT Curriculum document). Failure to participate in and successfully complete the required elements of the Core Curriculum will lead to withdrawal of ongoing funding support from the KRESCENT program.

 

Tenure

The duration of the Post-Doctoral Fellowship will be either two or three years, preference may be given to 3 year Post-Doctoral Fellowship applications.

The award will normally commence on July 1 and will run for the eligible duration.

During tenure of the award the awardee shall devote 80% to the purpose of the award in research.  The awardee may, with the approval of the supervisor, engage in and receive remuneration for departmental activities, including undergraduate teaching, that contribute to his/her development as a researcher.  However, these activities must not interfere with the primary purpose of the award.  Notification of any consideration for extra remuneration should be forwarded to the Chair of the Program Steering Committee of the KRESCENT program.

An award may be terminated at any time for good cause by the awardee, the sponsoring institution or the KRESCENT program.

 

Stipend

The annual stipend is $ 65,000 (MD or equivalent degree) or $ 55,000 (Ph.D. without a MD or equivalent degree) without benefits. Successful applicants are expected to organize their own benefits with the host institution.

Stipends are valued in Canadian dollars and are taxable. It is expected that 50% of the award will be contributed by the KRESCENT Program and 50% will be contributed by the host institution.

 

Payment of Stipend

Awards will be paid to the institution where the award is held in quarterly installments.

 

Preparing Electronic Files

Electronic files must be submitted on a CD, DVD or USB . When naming your files, add numbers to your file names, in ascending order, so that the documents appear in correct order.

Name electronic files for Post-Doctoral Fellowships as follows:

00-LNAME 2013 KPDF Application.pdf
00-LNAME 2013 KPDF Application.doc (please include original application in MS Word format)
01-LNAME 2013 KPDF Letter 1.pdf (from proposed supervisor confirming acceptance of candidate and research  proposal)
01-LNAME 2013 KPDF Letter 2 .pdf (proof of offer of permanent position if applicable)
01-LNAME 2013 KPDF Letter 3 pdf (proof of institution's contribution to KRESCENT Award - condition eligibility form)
02-LNAME 2013 KPDF CV Applicant.pdf
02-LNAME 2013 KPDF CV Supervisor 1.pdf
02-LNAME 2013 KPDF CV Supervisor 2 .pdf (if applicable)
03-LNAME 2013 KPDF Publication 1.pdf
03-LNAME 2013 KPDF Publication 2.pdf
03-LNAME 2013 KPDF Publication 3.pdf
03-LNAME 2013 KPDF Publication 4.pdf
03-LNAME 2013 KPDF Publication 5.pdf

 

Application

Applications must be submitted on the prescribed forms, which are available on the KRESCENT Program Website or at the National Office of The Kidney Foundation of Canada.

The original application and one (1) PDF copy on CD, DVD or USB along with all addenda (see Application Checklist for details) must be forward to:

KRESCENT Program
Alya Niang
Administrative Coordinator
National Office
The Kidney Foundation of Canada
300-5165 Sherbrooke Street, West
Montreal, Quebec H4A 1T6

 

Applications and all addenda must be courier marked February 15, 2014. Applications courier marked later than February 15, 2014 will not be reviewed.

Important: The KRESCENT program has implemented a zero-tolerance policy for late and incomplete applications. Failure to adhere to the guidelines and regulations will result in rejection of an application, without possibility of appeal.

The KRESCENT Program is a Strategic Training Program developed and supported by:

                                                    


With additional generous support from:

AMGEN               Baxter Corporation               Merck-Frosst Canada Ltd.             Ortho Biotech              RocheShire BioChem Inc.

© 2005 The Kidney Foundation of Canada